Skip to main content
Log in

ETV-2 activated proliferation of endothelial cells and attenuated acute hindlimb ischemia in mice

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Ischemia is the reduction of blood flow to tissues by injury of blood vessels. Depending on the sites of tissues and grade of ischemia, ischemia can cause many serious complications. This study aimed to evaluate the effects of the E-twenty six (ETS) factor Ets variant 2 (ETV2) gene expression in angiogenesis and the effect of ETV2 gene therapy in a mouse model of hindlimb ischemia. The role of ETV2 on endothelial cell proliferation was evaluated in vitro. Knockdown of ETV2 expression was done using short hairpin RNA (shRNA) lentiviral viral particles. The ETV2 viral vector was injected into the skeletal muscles at the ligated and burned sites of the hindlimb and evaluated for its efficacy as a gene therapy modality for ischemia. Vascular regeneration in mice was indirectly evaluated by changes in mouse survival, necrotic grades of the leg, normal blood oxygen saturation level (SpO2), and blood flow by trypan blue injection assay. Preliminary data showed that ETV2 expression played a role in angiogenesis of endothelial cells. ETV2 overexpression could trigger and stimulate proliferation of skeletal endothelial cells. In vivo knockdown of ETV2 expression inhibited the auto-recovery of ischemic hindlimb, while overexpression of ETV2 helped to rescue leg loss and reduce necrosis, significantly improving angiogenesis in hindlimb ischemia. Our findings demonstrate that ETV2 gene therapy is a potentially effective modality for vascular regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Ali I, Hookham M, Schmidt T, Cantley N, Wilson M, Mullins A, Medina R, Stitt A, Brazil D (2013). Outgrowth endothelial cell responses to hypoxia: role for BMP/SMAD signalling? Paper presented at Proceedings of The Physiological Society (The Physiological Society)

  • Chen S, Chen X, Wu X, Wei S, Han W, Lin J, Kang M, Chen L (2016). Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia reperfusion-induced acute lung injury in rats. Gene Ther 24(1):3–11

  • Chisari A, Pistritto AM, Bellosta R, Ferraresi R, Danzi GB (2016). Upper limb ischemia from arterial thromboembolism: a comprehensive review of incidence, aetiology, clinical aspects, diagnostic tools, treatment options and prognosis. Minerva Cardioangiol 64(6):625–34

  • Craig MP, Grajevskaja V, Liao HK, Balciuniene J, Ekker SC, Park JS, Essner JJ, Balciunas D, Sumanas S (2015) Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 35:865–876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, Gessler M (2007) Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 313:1–9

    Article  CAS  PubMed  Google Scholar 

  • Farber A, Eberhardt RT (2016) The current state of critical limb ischemia: a systematic review. JAMA Surg 151(11):1070–1077

  • Foley TR, Waldo SW, Armstrong EJ (2016) Medical therapy in peripheral artery disease and critical limb ischemia. Curr Treat Options Cardiovasc Med 18:42

    Article  PubMed  Google Scholar 

  • Gabr H, Hedayet A, Imam U, Nasser M (2011) Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial. Exp Clin Transplant 9:197–202

    PubMed  Google Scholar 

  • Ginsberg M, James D, Ding BS, Nolan D, Geng F, Butler JM, Schachterle W, Pulijaal VR, Mathew S, Chasen ST et al (2012) Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFbeta suppression. Cell 151:559–575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goto T, Fukuyama N, Aki A, Kanabuchi K, Kimura K, Taira H, Tanaka E, Wakana N, Mori H, Inoue H (2006) Search for appropriate experimental methods to create stable hind-limb ischemia in mouse. The Tokai journal of experimental and clinical medicine 31:128–132

    PubMed  Google Scholar 

  • Ieronimakis N, Balasundaram G, Reyes M (2008) Direct Isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PLoS One 3:e1753

    Article  PubMed Central  Google Scholar 

  • Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG et al (2016) Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene Ther 23:306–312

    Article  CAS  PubMed  Google Scholar 

  • Lee D, Park C, Lee H, Lugus JJ, Kim SH, Arentson E, Chung YS, Gomez G, Kyba M, Lin S et al (2008) ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2:497–507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liang L, Li Z, Ma T, Han Z, Du W, Geng J, Jia H, Zhao M, Wang J, Zhang B et al (2016) Transplantation of human placenta derived mesenchymal stem cell alleviates critical limb ischemia in diabetic nude rat. Cell Transplant 26(1):45–61

  • Lindgren AG, Veldman MB, Lin S (2015) ETV2 expression increases the efficiency of primitive endothelial cell derivation from human embryonic stem cells. Cell Regen (Lond) 4:1

    Google Scholar 

  • Liu F, Li D, Yu YY, Kang I, Cha MJ, Kim JY, Park C, Watson DK, Wang T, Choi K (2015) Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. EMBO Rep 16:654–669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Madaric J, Klepanec A, Valachovicova M, Mistrik M, Bucova M, Olejarova I, Necpal R, Madaricova T, Paulis L, Vulev I (2016) Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia. Stem Cell Res Ther 7:116

    Article  PubMed  PubMed Central  Google Scholar 

  • Matsumoto T, Tanaka M, Yoshiya K, Yoshiga R, Matsubara Y, Horiuchi-Yoshida K, Yonemitsu Y, Maehara Y (2016) Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101. Sci Rep 6:30035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS, Simon MC (2010) O(2) regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12:1007–1013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Molavi B, Zafarghandi MR, Aminizadeh E, Hosseini SE, Mirzayi H, Arab L, Baharvand H, Aghdami N (2016) Safety and efficacy of repeated bone marrow mononuclear cell therapy in patients with critical limb ischemia in a pilot randomized controlled trial. Arch Iran Med 19:388–396

    PubMed  Google Scholar 

  • Morita R, Suzuki M, Kasahara H, Shimizu N, Shichita T, Sekiya T, Kimura A, Sasaki K, Yasukawa H, Yoshimura A (2015) ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proc Natl Acad Sci U S A 112:160–165

    Article  CAS  PubMed  Google Scholar 

  • Oh SY, Kim JY, Park C (2015) The ETS factor, ETV2: a master regulator for vascular endothelial cell development. Mol Cells 38:1029–1036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park C, Lee TJ, Bhang SH, Liu F, Nakamura R, Oladipupo SS, Pitha-Rowe I, Capoccia B, Choi HS, Kim TM et al (2016) Injury-mediated vascular regeneration requires endothelial ER71/ETV2. Arterioscler Thromb Vasc Biol 36:86–96

    Article  CAS  PubMed  Google Scholar 

  • Peng Z, Yang X, Qin J, Ye K, Wang X, Shi H, Jiang M, Liu X, Lu X (2016) Glyoxalase-1 overexpression reverses defective proangiogenic function of diabetic adipose-derived stem cells in streptozotocin-induced diabetic mice model of critical limb ischemia. Stem Cells Transl Med 6(1):261–271

  • Reyes M, Chamberlain JS, Krishnamurty A (2006) Characterization, isolation and angiogenesis of endothelial cells derived from skeletal muscle. Blood 108:1821–1821

    Article  Google Scholar 

  • Sumanas S, Choi K (2016) ETS transcription factor ETV2/ER71/Etsrp in hematopoietic and vascular development. Curr Top Dev Biol 118:77–111

    Article  CAS  PubMed  Google Scholar 

  • Tian F, Zhou AX, Smits AM, Larsson E, Goumans MJ, Heldin CH, Boren J, Akyurek LM (2010) Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro. Biochem Biophys Res Commun 392:283–288

    Article  CAS  PubMed  Google Scholar 

  • Van Pham P, Vu NB, Nguyen HT, Huynh OT, Truong MT-H (2016) Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia. Stem Cell Research & Therapy 7:104

    Article  Google Scholar 

  • Vu NB, Bui ANT, Ngoc-Le Trinh V, Phi LT, Phan NK, Van Pham P (2014). A comparison of umbilical cord blood-derived endothelial progeni-tor and mononuclear cell transplantation for the treatment of acute hindlimb ischemia. Biomed Res Ther 1(1):9–20

  • Wang Y, Fan L, Meng X, Jiang F, Chen Q, Zhang Z, Yan H (2016) Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats. Graefes Arch Clin Exp Ophthalmol 254(10):1957–1965

  • Xiang Q, Hong D, Liao Y, Cao Y, Liu M, Pang J, Zhou J, Wang G, Yang R, Wang M et al (2016) Overexpression of Gremlin1 in mesenchymal stem cells improves hindlimb ischemia in mice by enhancing cell survival. J Cell Physiol 232(5):996–1007

Download references

Acknowledgements

This research was funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106-YS.06-2013.37.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phuc Van Pham.

Ethics declarations

Competing interests

The authors declare they have no competing interests.

Additional information

Editor: Tetsuji Okamoto

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Pham, P., Vu, N.B., Nguyen, H.T. et al. ETV-2 activated proliferation of endothelial cells and attenuated acute hindlimb ischemia in mice. In Vitro Cell.Dev.Biol.-Animal 53, 616–625 (2017). https://doi.org/10.1007/s11626-017-0151-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-017-0151-4

Keywords

Navigation